Background/Aims: This study aimed to investigate the anti-inflammatory activity of Berbamine (BER), a bisbenzylisoquinoline alkaloid extracted from Berberis amurensis (Xiao Bo An), and the underlying mechanisms. Methods: Macrophages and neutrophils were treated with BER in vitro and stimulated with LPS and fMLP. The effects of BER on the expression of proinflammatory mediators in macrophages were evaluated with quantitative RT-PCR and ELISA. The effects of BER on the activation and superoxide release of neutrophils were determined with flow cytometry and WST-1 reduction test. The inhibitory effects of BER on the activation of signaling pathways related to inflammatory response in macrophages were evaluated by western blot analysis. In addition, a mouse peritonitis model was made by peritoneal injection of thioglycollate medium and anti-inflammatory effects of BER were investigated in vivo by quantitative analysis of pro-inflammatory factor production and leukocyte exudation. Results: BER significantly inhibited inflammatory factor expression by LPS-stimulated macrophages and suppressed activation and superoxide release of fMLP-stimulated neutrophils. In the mouse peritonitis model, BER significantly inhibited the activation of macrophages and exudation of neutrophils. According to analysis, BER significantly suppressed phosphorylation of NF-κB and MAPK (JNK and ERK1/2) signaling pathways in LPS-stimulated macrophages. Conclusions: Collectively, data from this study suggest that BER has anti-inflammatory potential, which is effected via inhibition of NF-κB and MAPK signaling pathways, and thus holds promise for treatment of inflammatory disease.
Introduction
A properly-regulated inflammatory response protects the host from infection and aids in restoring structure and function of damaged tissues after injury. However, severe or persistent inflammation may lead to a variety of serious acute and chronic diseases, such Jia et 
Peritonitis
Male BALB/c mice (6-8 weeks old) were purchased from Charles River Laboratory, China (Beijing), and maintained under specific pathogen-free conditions at 22±2 °C and 55 ± 10 % humidity, on a 12 h/12 h light/dark cycle. All protocols conform to National Institutes of Health (NIH) guidelines, and animal care was performed in compliance with the Principles of Laboratory Animal Care. The study was approved by the Ethical Committee on Animal Research in Beijing University of Traditional Chinese Medicine (Beijing, China).
Mice were randomly assigned to the following five groups, (each group, n=6), named: Vehicle, Thioglycollate medium (TM), TM + Dexamethasone (DEX, 5 mg/kg), TM + BER (5 mg/kg), TM + BER (25 mg/kg). TM + BER groups received an intragastric bolus of BER (5 or 25 mg/kg, dissolved in 0.5 % carboxymethylcellulose sodium). Vehicle group, TM group and TM + DEX groups received 0.5 % carboxymethylcellulose sodium (CMC-Na (10 ml/kg). One hour after intragastric administration of BER, 3 % TM was given to all TM groups by intraperitoneal injection (2 ml/mouse), and an equal volume of 0.9 % NaCl solution was given to the Vehicle group. At 4 h post-TM administration, subject peritonea were lavaged with 5 ml of PBS, which lavage fluids were then collected.
Cell viability
The RAW264.7 cells were inoculated to 96-well plates, where they incubated for 24 h before the cells were incubated again, with or without BER, for another 24 h. Next, the cell medium was discarded and 100 μl of 0.5 mg/ml MTT was added, then incubated for 4 h, after which the MTT solution was discarded and 150 μl of dimethyl sulfoxide was added to each well to dissolve the crystals. Once culture steps were complete, plates were detected at a wavelength of 570 nm on a microplate reader. Optical density (OD) values are used to indicate levels of cell viability.
RNA extract and real-time PCR
RAW264.7 cells were seeded in 6-well plates. After 24 h of incubation, the cells were pretreated with BER for 1h, then stimulated by LPS (0.1 μg/ml) for 6 h. Using an Reverse Transcription kit (Promega, Madison, WI, USA), sample total RNA was subsequently extracted and reverse-transcribed to cDNA at 42 °C for 30 min, which was in turn amplified using PCR Supermix kit. Sequences of the GAPDH, TNF-α, IL-6, IL-1β, COX2, MMP-2 and MMP-9 primers appear in Table 1 . Amplification reactions were performed for one cycle at 95 °C for 1 min, then 40 cycles at 95 °C for 5 s and 60 °C for 40 s, followed by one cycle of melting curve determination. The amount of mRNA in each sample was calculated and normalized to the levels of GAPDH mRNA. [17] [18] [19] Measurement of cytokines by ELISA RAW264.7 cells were seeded in 96-well plate and incubated for 24 h, after which the cells were pretreated with BER for 1 h, then stimulated with LPS for 6 h. Applying ELISA, cell medium levels of TNF-α, IL-6, IL-1β , PGE2 MMP-2 and MMP-9 were then measured.
From inoculated and lavaged mouse peritonea, the lavage fluids were concentrated and resulting supernatants collected, from which levels of TNF-α and IL-6 were quantified by ELISA.
Flow cytometry
To measure the cytotoxicity of BER on neutrophils, isolated neutrophils were seeded in 24-well plates, which cells were pretreated with BER for 1 h, then cultured with or without fMLP (1μM) stimulation for 12 h. To determine the effects of BER on activation of neutrophils, isolated neutrophils were seeded in 24 well-plates, then pretreated with BER for 1 h before stimulation with fMLP (1μM) for 2 h. Thus-prepared cells were collected, suspended in staining buffer (1 % BSA in PBS), then stained with FITC-conjugated antiCD11b and PE-conjugated anti-CD62L at 4 °C for 30 min. Finally, the conjugated samples were washed with staining buffer and analyzed by flow cytometry.
From inoculated mice, peritoneal lavage fluids were concentrated, suspended in staining buffer and stained with APC-conjugated anti-Gr-1, FITC-conjugated anti-CD11b and PE-conjugated anti-F4/80 at 4 °C for 30 min. Then, the samples were washed and analyzed by flow cytometry. Identification of macrophages was based on positive labeling for F4/80 and CD11b, while neutrophils were identified by positive labeling for Gr-1 and CD11b.
Superoxide release determination
Isolated neutrophils were suspended in superoxide assay buffer, then incubated with BER 37 °C for 30 min, after which respiratory burst was stimulated by fMLP (1μM) for 2 h. Superoxide release was determined by WST-1 (water-soluble tetrazolium salts) reduction test according to the manufacture's protocol.
Western blot analysis
To prepare for blot analysis, RAW264.7 cells were seeded in 6-well plates and incubated for 24 h, after which the cells were pretreated with BER for 1 h, then stimulated by LPS for 30 min or 6 h. Once stimulated, the cells were collected using a cell scraper and total cell proteins were extracted by RIPA lysis buffer. [20] Next, proteins were separated by 10 % SDS-PAGE and transferred to polyvinylidenedifluoride membranes. The protein-bearing membranes were then blocked in 5% skim milk for 1 h and incubated overnight at 4 °C with antibodies against p65, I-κB, p38, ERK1/2, JNK, phosphorylated p65, phosphorylated I-κB phosphorylated p38, phosphorylated ERK1/2, phosphorylated JNK and COX2. Incubated protein membranes were then rinsed and incubated once again with horseradish peroxide-conjugated secondary antibodies for 2h at room temperature, and rinsed once more. The resulting bands were visualized using ECL (enhanced chemiluminescence) reagents and band density analysis was performed using Quantity One (Bio-Rad, California, USA).
Statistical analysis
All data are here expressed as mean ± standard error (SEM) of values from at least three independent experiments. Statistical analyses were performed with GraphPad Prism 5.0. One-way ANOVA was used to evaluate the difference among multiple groups and Dunnett's test was followed to compared the difference between two groups. P values less than 0.05 were considered to be statistically significant.
Results

Effects of BER on cell viability of RAW264.7 cells and apoptosis of neutrophils
The potential cytotoxicity of BER on RAW264.7 cells was evaluated by MTT assay, from which results (Fig. 1 A) show that BER at the concentration up to 50 μM, but not 100 μM, had no cellular toxicity on RAW264.7 cells.
The apoptosis analysis results ( Fig. 1 B) also show that BER had no pro-apoptosis effects on neutrophils at concentrations up to 50 μM, while at the concentration of 100 μM had significantly pro-apoptosis effects.
Effects of BER on LPS-induced cytokine expression and secretion by macrophages
Macrophages play a key role during inflammatory response initiation and exert proinflammatory effects by secreting cytokines, such as TNF-α, IL-6 and IL-1β. Therefore, we investigated the effects of BER on LPS-induced TNF-α, IL-6 and IL-1β expression, as well as Cell
Effects of BER on LPS-induced MMPs expression and secretion by macrophages
During inflammatory response, MMPs produced by macrophages also play important roles and contribute to infiltration of leukocytes into tissues [7, 8, 21] . Therefore, we investigated the effects of BER on LPS-induced MMP-2 and MMP-9 expression, as well as secretion by macrophages. The results (Fig. 4) indicate that BER slightly suppresses mRNA transcription and protein secretion of MMP-2 and MMP-9 by macrophages in concentration of 10 μM.
Effects of BER on neutrophil activation
During inflammatory response, neutrophils form another important cell type. After determining the inhibitory effects of BER on the activation of and cytokine secretion by macrophages, we also investigated the effects of BER on the activation of neutrophils. Our results (Fig. 5) show that BER significantly suppresses up-regulation of CD11b and downregulation of neutrophils at 2.5-10 μM in a dose-dependent manner.
Effects of BER on the production of superoxide by neutrophils
Superoxide release by hyper-activated neutrophils is the main cause of tissue damage during inflammatory response. After determining the inhibitory effects of BER on the activation of neutrophils, we further investigated the effects of BER on superoxide release by neutrophils. Here, results (Fig. 6) indicate that BER intensively inhibits superoxide release by neutrophils in a dose-dependent manner at 2.5-10 μM.
Effects of BER on peritonitis
Following determination of the inhibitory effects by BER on the activation of macrophages and neutrophils, anti-inflammatory effects in vivo and therapeutic potential for treatment of inflammatory disease were investigated. In the mouse peritonitis model study, results (Fig. 7) demonstrate that the population of neutrophils in peritoneal cavities of subject mice significantly increased after stimulation by 3 % TM, while the number of macrophage intensively decreased. BER, just like dexamethasone, significantly suppressed the up-regulation of neutrophils and the down-regulation of macrophages at 5 and 25 mg/kg. Furthermore, BER also significantly inhibited the production of TNF-α and IL-6 in peritoneal cavity at the same concentration (Fig. 8) .
Effects of BER on the activation of NF-κB and MAPK signaling pathways
Previous research establishes that NF-κB and MAPK signaling pathways play critical roles during inflammatory response regulation. In order to investigate the underlying mechanism of BER inflammatory response inhibition, the effects of BER on the activation of NF-κB and MAPK signaling pathways was examined. Fig. 9 show that p65, I-κB, p38, ERK1/2 and JNK were highly phosphorylated in LPS-treated RAW264.7 cells and the phosphorylation levels of p65, I-κB and JNK were significant inhibited by BER, in a dose-dependent manner at 2.5-10 μM. Furthermore, BER could significantly inhibit the phosphorylation of ERK1/2 at 10 μM. 
Discussion
Studies confirm that over-activation of innate immune cells plays a critical role in the pathogenesis of local and systemic inflammatory disorders. As well, results here suggest that controlling activation of macrophages and neutrophils can attenuate inflammatory disorders [1] [2] [3] [4] [5] [6] . Previous studies have shown that BER and its derivatives can inhibit tumor growth by modulating NF-κB signaling pathway and apoptosis [14, [21] [22] [23] [24] . In this study, we first determined cytotoxicity of BER on macrophages and neutrophils by cell viability and apoptosis assays, which results indicate that BER is not cytotoxic on macrophages and neutrophils at concentrations up to 50 μM. Next, we investigated anti-inflammatory effects of BER in vitro under the previous dosages without cytotoxic result.
Macrophages play very important roles during inflammatory response by secreting pro-inflammatory factors, such as TNF-α, IL-6 and IL-1β [25] [26] [27] . By use of LPS-induced macrophages, we determined the effects of BER on the expression and secretion of the proinflammatory factors, TNF-α, IL-6 and IL-1β. Here, results indicate that BER intensively inhibits the expression and secretion of TNF-α, IL-6 and IL-1β, thus showing potential anti-inflammatory activity. PGE2 is another key mediator of inflammatory secretion by macrophages and contributes to pain hypersensitivity by promoting sensory neuron hyperexcitation. Inhibition of COX2 expression, which is the key synthase of PGE2, as well as synthesis of PGE2 during inflammation, can significantly attenuate inflammatory pain [28, 29] . In order to comprehensively clarify the anti-inflammatory activity of BER, we determined the effects of BER on the expression of COX2 and PGE2 production, which results show that BER also intensively inhibits the expression of COX2 and PGE2 production by macrophages. In addition, macrophages can release MMPs to facilitate infiltration of immune cells during inflammatory response [7, 8] . So we also evaluated the effects of BER on the expression and secretion of MMP2 and MMP-9. The results show that BER slightly suppresses the expression and secretion of MMP-2 and MMP-9 which is consistent with previous report in human breast cancer [21] .
Another important innate immune cell type is the neutrophil, which plays key roles during inflammatory response. At sites of inflammation, pro-inflammatory factors induce the transition of circulating neutrophils from a quiescent, poorly-adhesive state to a primed, strongly-adhesive phenotype [30, 31] . Through the release of reactive oxygen radicals, digestive enzymes and antimicrobial peptides, neutrophils then eliminate the invading microorganisms, coincidentally damaging normal tissues in cases inflammatory disease [32] [33] [34] . In this study, the effects of BER on the expression of adhesive molecules are defined, which results show that BER significantly inhibits down-regulation of CD11b and upregulation of CD62L on the surface of neutrophils. Furthermore, we found that BER also inhibits superoxide release by fMLP-stimulated neutrophils.
Once the inhibitory effects of BER on the activation of macrophages and neutrophils were determined in vitro, the anti-inflammatory effects of BER were elucidated through a mouse peritonitis model. In this case, results show that macrophages significantly decrease, neutrophils intensively increase and exhibit strong inflammatory response in the peritoneal cavity of test subjects after thioglycollate medium injection. The administration of BER remarkably inhibited consumption by macrophages and exudation of neutrophils. In addition, BER also suppressed the production of the pro-inflammatory factors, TNF-α and IL-6.
NF-κB and MAPK signaling pathways play key roles in signal transduction during inflammatory response [35] [36] [37] [38] . After determining the anti-inflammatory effects of BER, experiments in vitro and in vivo clarified the underlying mechanism by monitoring the activation of NF-κB and MAPK signaling pathways as induced by LPS. Again, results show that BER significantly suppresses phosphorylation of p65, IκB, JNK and ERK1/2.
In summary, a series of mutually-qualifying tests demonstrate that BER exerts antiinflammatory effects by inhibiting the activation of macrophages and neutrophils through the blocking NF-κB, ERK1/2 and JNK signaling pathways. Thus, BER shows great potential for development drug therapy against inflammatory disorders.
